CymitQuimica logo

CAS 4651-51-8

:

Dihydrobrassicasterol

Description:
Dihydrobrassicasterol is a sterol compound that is structurally related to brassicasterol, which is commonly found in various plant sources, particularly in cruciferous vegetables. It is characterized by its steroidal structure, featuring a hydroxyl group that contributes to its classification as a sterol. This compound is notable for its role in cellular membranes, where it can influence membrane fluidity and stability. Dihydrobrassicasterol is also of interest in the field of biochemistry and nutrition due to its potential health benefits, including cholesterol-lowering effects and contributions to overall lipid metabolism. Its presence in dietary sources may have implications for human health, particularly in relation to cardiovascular disease and metabolic disorders. Additionally, research into dihydrobrassicasterol may provide insights into its biosynthesis and the enzymatic pathways involved in sterol metabolism. Overall, this compound represents a significant area of study within phytochemistry and nutrition science.
Formula:C28H48O
InChI:InChI=1S/C28H48O/c1-18(2)19(3)7-8-20(4)24-11-12-25-23-10-9-21-17-22(29)13-15-27(21,5)26(23)14-16-28(24,25)6/h9,18-20,22-26,29H,7-8,10-17H2,1-6H3/t19-,20+,22-,23-,24+,25-,26-,27-,28+/m0/s1
InChI key:InChIKey=SGNBVLSWZMBQTH-ZRUUVFCLSA-N
SMILES:C[C@@]12[C@]([C@]3([C@@]([C@]4(C)C(=CC3)C[C@@H](O)CC4)(CC1)[H])[H])(CC[C@@]2([C@@H](CC[C@@H](C(C)C)C)C)[H])[H]
Synonyms:
  • Δ22-Dihydrobrassicasterol
  • Δ5-Ergostenol
  • (3β)-Ergost-5-en-3-ol
  • Ergost-5-en-3β-ol
  • Ergost-5-en-3-ol, (3β)-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
  • 22,23-Dihydrobrassicasterol
    Biosynth
    + Info

    22,23-Dihydrobrassicasterol

    Controlled Product
    CAS:
    <p>22,23-Dihydrobrassicasterol is a sterol present in rhizoma gastrodiae that has been shown to inhibit the growth of oral pathogens. It also has been found to have cholesterol-lowering effects and can be used as an antimicrobial agent to treat gastrointestinal diseases. 22,23-Dihydrobrassicasterol has been found to have inhibitory effects on human serum processes such as the process of producing fibroblasts and on physiological functions such as the inhibition of hepatic steatosis. The pharmacokinetic properties of this drug are not well understood, but it appears to be absorbed from the gut and excreted in urine.</p>
    Formula:C28H48O
    Purity:Min. 95%
    Molecular weight:400.68 g/mol

    Ref: 3D-FD159340

    ne
    To inquire